GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Altman Z-Score

IVD Medical Holding (HKSE:01931) Altman Z-Score : 1.97 (As of May. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 2.01 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

IVD Medical Holding has a Altman Z-Score of 1.97, indicating it is in Grey Zones. This implies that IVD Medical Holding is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for IVD Medical Holding's Altman Z-Score or its related term are showing as below:

HKSE:01931' s Altman Z-Score Range Over the Past 10 Years
Min: 2.01   Med: 2.63   Max: 3.36
Current: 2.01

During the past 8 years, IVD Medical Holding's highest Altman Z-Score was 3.36. The lowest was 2.01. And the median was 2.63.


IVD Medical Holding Altman Z-Score Historical Data

The historical data trend for IVD Medical Holding's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Altman Z-Score Chart

IVD Medical Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial 3.36 2.63 2.77 2.53 2.32

IVD Medical Holding Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 - 2.53 - 2.32

Competitive Comparison of IVD Medical Holding's Altman Z-Score

For the Medical Distribution subindustry, IVD Medical Holding's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IVD Medical Holding's Altman Z-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where IVD Medical Holding's Altman Z-Score falls into.



IVD Medical Holding Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

IVD Medical Holding's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.3726+1.4*0+3.3*0.0753+0.6*1.0445+1.0*0.6454
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was HK$5,234 Mil.
Total Current Assets was HK$3,262 Mil.
Total Current Liabilities was HK$1,312 Mil.
Retained Earnings was HK$0 Mil.
Pre-Tax Income was HK$371 Mil.
Interest Expense was HK$-23 Mil.
Revenue was HK$3,378 Mil.
Market Cap (Today) was HK$1,598 Mil.
Total Liabilities was HK$1,530 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(3261.882 - 1311.574)/5233.789
=0.3726

X2=Retained Earnings/Total Assets
=0/5233.789
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(371.151 - -23.013)/5233.789
=0.0753

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1598.416/1530.375
=1.0445

X5=Revenue/Total Assets
=3378.012/5233.789
=0.6454

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

IVD Medical Holding has a Altman Z-Score of 1.97 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


IVD Medical Holding  (HKSE:01931) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


IVD Medical Holding Altman Z-Score Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


IVD Medical Holding (HKSE:01931) Business Description

Traded in Other Exchanges
N/A
Address
Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN
IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.
Executives
Leung King Sun
Wu Meizhen 2201 Interest of corporation controlled by you
China International Trust Limited 2201 Interest of corporation controlled by you
Wu Yanfeng 2201 Interest of corporation controlled by you
Wu Mingcong 2201 Interest of corporation controlled by you
Wu Junfeng 2201 Interest of corporation controlled by you
Shen Li 2201 Interest of corporation controlled by you
Nd Medical Technology Limited 2201 Interest of corporation controlled by you
Ma Zhouwei 2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited 2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited 2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited 2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited 2201 Interest of corporation controlled by you
3w.com Holding Limited 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines